*The following content is generated by AI and is for reference only.
Overview
Ticagrelor is a potent, reversible P2Y12 receptor antagonist used in cardiovascular therapy. Manufactured via complex organic synthesis involving chiral intermediates, its molecular formula is C23H25F6N7O (CAS No. 466340-77-4).
Application
- Pharmaceutical Manufacturing: Production of antiplatelet tablets for acute coronary syndrome management.
- Clinical Research: Used as an active pharmaceutical ingredient in clinical trials for thrombosis prevention.
- Distribution: Wholesale supply to hospitals and pharmacies for post-stenting protocols.
Precautions
Contraindicated in patients with active bleeding or history of intracranial hemorrhage. Store under controlled room temperature away from moisture. Strict adherence to dosage guidelines is required to avoid excessive bleeding risks.